<DOC>
	<DOC>NCT01645371</DOC>
	<brief_summary>This qualitative research is to assess the validity of the stool symptom screener that will be used in patients with chronic opioid-induced constipation to determine the adequacy of their response to laxatives.</brief_summary>
	<brief_title>Assessing a Stool Symptom Screener in Patients With Chronic Opioid-Induced Constipation</brief_title>
	<detailed_description>Assessing the Content Validity of a Stool Symptom Screener in Patients with Chronic Opioid-Induced Constipation</detailed_description>
	<mesh_term>Constipation</mesh_term>
	<mesh_term>Analgesics, Opioid</mesh_term>
	<criteria>Receiving a stable maintenance opioid regimen (total daily dose of 301000mg of oral morphine, or equianalgesic amounts of 1 or more other opioid therapies) for a minimum of 4 weeks for noncancer related pain. Development of constipation symptoms since starting opioids. Taken laxatives to help with bowel movements for at least four days over the past 2 weeks. Receiving opioid regimen for treatment of pain related to cancer. Participated in any clinical trial or research study relating to opioid use and/or constipation within the past year. History of cancer within 5 years from the time of screening. Has medical condition(s) and/or treatment(s) associated with diarrhea, intermittent loose stools, or constipation (e.g., fecal incontinence or chronic idiopathic constipation). Has irritable bowel syndrome (IBS) or chronic functional constipation.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>84 Years</maximum_age>
	<verification_date>October 2014</verification_date>
	<keyword>opioid-induced constipation</keyword>
</DOC>